19171-Essential Thrombocythemia-NA-1517

Essential Thrombocythemia

A Randomized, Controlled Phase 3 Study of Pacritinib Versus Physician's Choice in Patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis with Severe Thrombocytopenia (Platelets Counts <50,000/µL) (PAC203)

  • Details

ClinicalTrials.gov ID: NCT03165734
Diagnosis Type: NA
USOR Number: 19171

  • Address

5236 W University Dr, Suite 1000
McKinney, TX 75071
P: (972) 542-8609

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.